Ligand validation:4CYV

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CYV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CYV_NAG_E_420	17%	39%	0.303	0.883	0.54	1.81	-	3	0	1	100%	0.9333
4CYV_NAG_A_401	14%	42%	0.3	0.858	0.53	1.67	-	3	0	1	100%	0.9333
4CYV_NAG_A_420	8%	37%	0.332	0.803	0.56	1.87	-	3	0	1	100%	0.9333
4CYV_NAG_C_420	7%	21%	0.281	0.733	0.59	2.63	-	4	0	1	100%	0.9333
4CYV_NAG_B_211	6%	48%	0.294	0.737	0.68	1.32	-	3	0	0	100%	0.9333
4CYV_NAG_D_211	2%	44%	0.353	0.637	0.78	1.36	1	2	1	0	100%	0.9333
4QY2_NAG_J_601	77%	75%	0.099	0.937	0.44	0.55	-	-	0	0	100%	0.9333
4QY1_NAG_D_601	77%	85%	0.109	0.947	0.3	0.44	-	-	1	0	100%	0.9333
4WSX_NAG_K_401	76%	21%	0.097	0.933	0.46	2.78	-	3	0	0	100%	0.9333
4QY0_NAG_J_601	68%	79%	0.132	0.945	0.35	0.51	-	-	0	0	100%	0.9333
6TWV_NAG_J_201	68%	48%	0.115	0.925	0.33	1.66	-	1	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.